Cardiac Ablation Technology Market Scope
Less complex functions and minimally invasive approaches make radiofrequency a suitable technology for the development of cardiac ablation devices. Another aspect that increases the suitability of this technology is its low-risk profile and high convenience factors, which increases its adoption. Atrial fibrillation (AF) is a major public health concern in the United States, affecting an estimated 2.3 million Americans. The prevalence of AF is projected to reach 5.6 to 12.1 million by the year 2050. AF is the most common sustained arrhythmia seen in clinical practice and accounts for approximately one-third of hospitalizations for cardiac dysrhythmias.
The market study is being classified by Type (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators and Microwave Ablators), by Application (Cardiac Rhythm Management [Cardiac Arrhythmia, Atrial Fibrillation, and Flutter, Tachycardia], Open Surgery and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Cardiac Ablation Technology market throughout the predicted period.
Advanced Cardiac Therapeutics (United States), Alcon Laboratories Inc. (United States), AngioDynamics, Inc. (United States), AtriCure, Inc. (United States), Biosense Webster Inc. (United States), Boston Scientific Corporation (United States), CONMED Corporation (United States), Medtronic Plc (United States), Olympus Corporation (Japan) and St Jude Medical, Inc. (United States) are some of the key players profiled in the study.
AdvanceMarketAnalytics has segmented the market of Global Cardiac Ablation Technology market by Type, Application and Region.
On the basis of geography, the market of Cardiac Ablation Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.
- Introduction of Next-Generation Ablation Products as well as Technologies
- Incresing Prevalence of Cardiovascular Diseases
- Growing Incidence of Cancer
- High Number of Ablation Procedures
- Growth Potential Offered By Emerging Markets
- Rising Awareness Related to Ablation Procedures
- Stringent Government Regulations
- The Concern Related Reuse and Reprocessing of Devices in Developing Countries
- Healthcare Cost-Containment Measures
Key Target AudienceCardiac Ablation Technology Providers, Government Regulatory Bodies, Private Research Organization, Government Research Organization and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase